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Key Clinical Message
This is the first reported case of fetal pericardial effusion in association with X-
linked adrenoleukodystrophy and hypocortisolism from a nonautoimmune
cause. Our hypothesis is that in experienced hands and after accurate genetic
counseling, isolated pericardial effusion can constitute an indication for a severe
metabolic disease.
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Case Report
A 26-year-old healthy was referred to our tertiary center
at 17+5 weeks of gestation with a diagnosis of pericardial
effusion (PE) seen at a routine ultrasound examination.
The pregnancy was developing normally and there was no
history of exposure to medical or toxic substances.
Fetal echocardiography revealed a small PE of about
3 mm in end-diastole, normal fetal heart structure,
rhythm, and function. There was no evidence of extracar-
diac malformations or hydrops.
Fetal biometry and the volume of amniotic fluid were
normal. Fetal anemia was excluded by evaluating middle
cerebral artery Doppler velocimetry. Viral screening
(TORCH complex and parvovirus B19) in maternal
serum was negative.
The patient was counseled that the presence of isolated
PE could result in chromosomal aneuploidies or some
genetic disease and then recommended to genetic counsel-
ing. This was the first pregnancy of a nonconsanguineous
couple and they reported negative history for congenital
malformations. The woman referred that a maternal uncle
died in the young age for unknown reason, but he suffered
of intellectual disability and spasticity. Her brother pre-
sented the following clinical signs: progressive neurode-
generation, paraparesis, cognitive decline, seizures, and
ataxia.
Family history revealed the presence of possible X-
linked genetic disease and we suspected X-linked adreno-
leukodystrophy (X-ALD). In the same time, we performed
the entire gene sequence of ABCD1 gene in the mother
and fetus. The woman resulted carrier of the c.919 C>T
(p.Gln307*) mutation.
The male fetus presented the same mutation identified
in his mother (Fig. 1); fetal karyotyping after amniocente-
sis was normal (46,XY). The parents opted to continue
the pregnancy in anticipation of a possible hematopoietic
stem cell transplantation. Serial fetal echocardiography
showed a constant small PE not requiring pericardiocen-
tesis (Fig. 2).
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At 39+2 weeks of gestation, a male infant was deliv-
ered. His weight was 3350 g, length 49 cm and the Apgar
score 9/10. He had a normal clinical examination and the
postnatal echocardiography showed same value of PE
(3 mm).
Venous blood spot measurement of C26:0 lys-
ophosphatidylcholine (26:0-lyso-PC) was performed by
tandem mass spectrometry (MS/MS) demonstrating an
altered level, even if the boy was asymptomatic.
Discussion
PE is defined as a pericardial fluid collection larger than 2
mm; generally, PEs measuring < 4 mm are categorized as
small, while those measuring ≥ 4 mm are categorized as
large [1] . Isolated PE without other fluid collections covers
a wide spectrum of etiologies from transient forms to
genetic and chromosomal anomalies.
A high incidence (30%) of chromosomal anomalies,
mainly trisomy 21, has been reported in isolated PE [2].
Infections (toxoplasma, cytomegalovirus, rubella virus,
herpes virus, parvovirus B19) can also cause PEs [3]. Car-
diac etiologies of PE can be tumors (teratoma, rhabdomy-
oma), a pericardial capillary hemangioma and ventricular
outpouchings such as diverticula and aneurysms [4,5].
The etiology, therefore, is diverse and PE can also be a
benign finding in milder forms in the absence of sono-
graphic abnormalities and it may also be present in other-
wise normal, healthy fetuses [1]. In isolated PE, the
inflammation of pericardium as a possible cause of this
sonographic finding must also be considered [2].
We describe a case of isolated PE, not related to struc-
tural heart anomalies or fetal arrhythmias.
Genetic counseling revealed familiarity for X-linked
adrenoleukodystrophy (X-ALD) (OMIM #300100), one of
the most frequent peroxisomal diseases affecting the adre-
nal cortex, the central nervous system, and testicular
function [6]. The incidence in males with X-ALD is esti-
mated to be about 1:21,000. There is a broad phenotype
of X-ALD, which ranges from the childhood cerebral
form characterized by rapid progression to a vegetative
state or death within 1–2 years (31–35%), to the slowly
progressive adrenomyeloneuropathy (AMN) in adults
(40–46%) [6]. Primary adrenal insufficiency (AI), or
Addison’s disease, may precede overt neurological
involvement, particularly when X-ALD manifests at a
younger age [7] . X-ALD results from pathogenetic vari-
ants including deletions, missense, nonsense, frameshift,
and splice defects involving the ABCD1 gene.
To date, the only identified storage products in this
disorder consist of very long chain fatty acids (VLCFA) in
the serum, brain, and adrenal glands [6] leading to hypo-
cortisolism, which presents typical addisonian features
such as dehydration, hypoglycemia, hyperkalemia, etc.
[7].
We report, for the first time (to our knowledge), PE in
a fetus affected by X-ALD. He inherited the mutation
c.919 C>T (p.Gln307*) in the ABCD1 gene from the
mother. This mutation was described by Montagna et al.
[8] in an Italian family. The pathogenicity is quite
straightforward because it leads to premature translation
termination.
In order to define the pathogenicity of variant, all the
following criteria were applied: variant was not included
in dbSNP142; variant was reported in HGMD
(www.hgmd.cf.ac.uk); variant did not occur in healthy
controls within the “1000 Genomes Project” database
(www.1000genomes.org); variant did not occur within
Figure 1. Sanger sequencing of ABCD1 gene in the carrier mother
that identified the heterozygous mutation C>T. The arrow indicate
the base pair substitution.
Figure 2. Two dimensional echocardiography with four-chamber
view demonstrating the pericardial effusion (asterisk) in the woman at
19 weeks’ gestation. LV, left ventricle; RV, right ventricle.
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the Kaviar-hg19 database (http://db.systemsbiology.net/
kaviar/).
In the light of the family history, we might consider
that maternal uncle died for X-ALD, and that the affected
brother of the fetus’ mother has severe phenotype, and
apparently no PE.
At the moment we have no information about the pos-
sible association of this variant with pericarditis. Recently,
Taxter et al. [9] for the first time described a small PE in
the absence of autoimmunity or particular infectious eti-
ologies in a pediatric patient affected by X-ALD. They
suppose that, even in the absence of autoimmunity,
chronic hypocortisolism itself might provoke pericarditis.
Our hypothesis is that also fetal PE could be the conse-
quence of fetal adrenal insufficiency that appeared early
in the development and that inflammation may induce
PE.
Tumor necrosis factor (TNF) as a mediator of inflam-
mation is a potent regulator of steroidogenesis and cell
viability in adrenocortical cells, and may also inhibit adre-
nocorticotropin-induced cortisol production [10]. Conse-
quently, we speculate that the subsequent fetal
hypocortisolism in turn may prevent to remove PE which
is the expression of pericardial inflammation. PE could be
an echographic marker of X-ALD and hyporcotisolism
itself may be one of possible causes of isolated fetal PE.
In conclusion, in these circumstances an appropriated
genetic counseling and multidisciplinary approach are the
most effective goals to achieve a given diagnosis even in
the absence of a specific ultrasound phenotype.
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